SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate.
Matharu
M S
MS
Headache Group, Institute of Neurology, Queen Square, London, United Kingdom.
Boes
C J
CJ
Goadsby
P J
PJ
D020785:Central Nervous System Vascular Malformations / Q000150:complications*; D003229:Conjunctival Diseases / Q000188:drug therapy* / Q000209:etiology; D004351:Drug Resistance; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use*; D020773:Headache Disorders / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D020325:Migraine with Aura / Q000188:drug therapy; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D012032:Refractory Period, Electrophysiological; D013577:Syndrome; D000077236:Topiramate
D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose